Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome

This study has been completed.
Information provided by:
Telik Identifier:
First received: May 6, 2002
Last updated: May 30, 2008
Last verified: June 2005